DK0703923T3 - Faktor VII afledte peptider - Google Patents

Faktor VII afledte peptider

Info

Publication number
DK0703923T3
DK0703923T3 DK94918437T DK94918437T DK0703923T3 DK 0703923 T3 DK0703923 T3 DK 0703923T3 DK 94918437 T DK94918437 T DK 94918437T DK 94918437 T DK94918437 T DK 94918437T DK 0703923 T3 DK0703923 T3 DK 0703923T3
Authority
DK
Denmark
Prior art keywords
pct
date
sec
factor vii
derived peptides
Prior art date
Application number
DK94918437T
Other languages
Danish (da)
English (en)
Inventor
Ross Wentworth Stephens
Lars Orning
Kjell Steinar Sakariassen
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939312601A external-priority patent/GB9312601D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Application granted granted Critical
Publication of DK0703923T3 publication Critical patent/DK0703923T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94918437T 1993-06-18 1994-06-17 Faktor VII afledte peptider DK0703923T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939312601A GB9312601D0 (en) 1993-06-18 1993-06-18 Peptides
GB9409335A GB9409335D0 (en) 1993-06-18 1994-05-10 Peptides
PCT/GB1994/001315 WO1995000541A1 (en) 1993-06-18 1994-06-17 Factor vii-derived peptides

Publications (1)

Publication Number Publication Date
DK0703923T3 true DK0703923T3 (da) 1999-06-21

Family

ID=26303086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94918437T DK0703923T3 (da) 1993-06-18 1994-06-17 Faktor VII afledte peptider

Country Status (15)

Country Link
US (1) US5962418A (sv)
EP (1) EP0703923B1 (sv)
JP (1) JPH08511794A (sv)
CN (1) CN1125450A (sv)
AT (1) ATE171950T1 (sv)
CA (1) CA2164422A1 (sv)
CZ (1) CZ334095A3 (sv)
DE (1) DE69413817T2 (sv)
DK (1) DK0703923T3 (sv)
FI (1) FI956055A (sv)
HU (1) HUT74873A (sv)
NO (1) NO955067L (sv)
NZ (1) NZ267453A (sv)
SK (1) SK156395A3 (sv)
WO (1) WO1995000541A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
GB9425380D0 (en) * 1994-12-15 1995-02-15 Nycomed Pharma As Peptides
GB9425381D0 (en) * 1994-12-15 1995-02-15 Nycomed Pharma As Peptides
US5837684A (en) * 1995-06-07 1998-11-17 Nycomed Imaging As Peptides
WO1999013063A1 (en) * 1997-09-09 1999-03-18 Nycomed Imaging As Factor vii fragments and analogs thereof and their use in the treatment of blood clottng disorders
WO1999013062A1 (en) * 1997-09-09 1999-03-18 Nycomed Imaging As Factors vii fragments and analogs thereof and their use in the treatment of blood clotting disorders
EP0987274A1 (en) 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Factor VIIa Inhibitors
EP1192270A2 (en) 1999-06-14 2002-04-03 Novo Nordisk A/S FVIIa/TF ACTIVITY INHIBITING COMPOUNDS
AU781618C (en) 1999-07-02 2006-03-16 Genentech Inc. FVIIa antagonists
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
US20060257359A1 (en) * 2005-02-28 2006-11-16 Cedric Francois Modifying macrophage phenotype for treatment of disease
AU2017206445B2 (en) 2016-01-15 2019-07-18 Rigshospitalet Quantitative pet imaging of tissue factor expression using 18F-labled active site inhibited factor VII
US20190358351A1 (en) 2016-11-17 2019-11-28 Minerva Imaging Aps 177-lu labeled active site inhibited factor vii

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
CA1298033C (en) * 1985-04-16 1992-03-24 Takaharu Tanaka Dipeptide derivative of fatty acid
US5087564A (en) * 1985-06-20 1992-02-11 Monsanto Company Release of recombinant peptides from polypeptides using V8 endopeptidase
US5047401A (en) * 1985-09-09 1991-09-10 Board Of Regents, The University Of Texas System Use of dipeptide alkyl esters to treat GVHD
AU4338689A (en) * 1988-09-23 1990-04-18 Corvas, Inc. Peptidyl inhibitors of the initiation of coagulation
ATE180834T1 (de) * 1990-01-29 1999-06-15 Zymogenetics Inc Antikoagulierende proteine
DE4007902A1 (de) * 1990-03-13 1991-09-19 Behringwerke Ag Synthetische peptide, die sequenzen aus faktor viia enthalten und deren verwendung
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
WO1993009804A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation

Also Published As

Publication number Publication date
AU691814B2 (en) 1998-05-28
HU9503593D0 (en) 1996-02-28
FI956055A (sv) 1996-01-26
FI956055A0 (sv) 1995-12-15
EP0703923A1 (en) 1996-04-03
EP0703923B1 (en) 1998-10-07
CN1125450A (zh) 1996-06-26
CZ334095A3 (en) 1996-07-17
NO955067D0 (no) 1995-12-14
NO955067L (no) 1995-12-14
AU6975594A (en) 1995-01-17
ATE171950T1 (de) 1998-10-15
SK156395A3 (en) 1996-06-05
DE69413817T2 (de) 1999-06-10
JPH08511794A (ja) 1996-12-10
CA2164422A1 (en) 1995-01-05
WO1995000541A1 (en) 1995-01-05
US5962418A (en) 1999-10-05
HUT74873A (en) 1997-02-28
NZ267453A (en) 1997-03-24
DE69413817D1 (de) 1998-11-12

Similar Documents

Publication Publication Date Title
DK0703923T3 (da) Faktor VII afledte peptider
IL129238A0 (en) N-(aryl/heteroarylacetyl) amino acid esters pharmaceutical compositions comprising same and methods for inhibiting b-amyloid peptide release and/ or its synthesis by use of such compounds
GR3019901T3 (en) Osteoinductive pharmaceutical formulations
EP0456152A3 (en) Peptidamides, their process of preparation and the agents containing these peptides as fibrin-thrombin clotting inhibitors
WO2000012541A3 (en) Cytotoxic peptides modified by bulky or lipophilic moieties
SE0002202D0 (sv) New peptides
BR9714358A (pt) Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
MY135057A (en) Dolastatin 15 derivatives
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
EP1309616A4 (en) PEPTIDES WITH INTEGRIN BINDING MOTIVATION AND TREATMENT METHODS FOR MUSCLE DISEASES (26.02.02)
WO2001005810A3 (de) CYCLISCHE PEPTIDDERIVATE ALS INHIBITOREN DES INTEGRINS αvβ¿6?
ES2153433T3 (es) Inhibidores de trombina bivalentes.
KR910007960A (ko) 항응고성 펩티드
CA2419423A1 (en) Conjugates of peptides and peptide mimetics having integrin inhibitor properties
HU0102043D0 (en) Pharmaceutical compounds which interact with an ca2+ channel alpha2delta subunit
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
DE69834929D1 (de) Verwendung eines organspezifischen ernährungmittels
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
DE69922150D1 (de) Deoxyhypusin reagenz und peptide
NO942544L (no) Peptidbindingsenhet inneholdende metylenfosfinsyre
IL117812A0 (en) N-substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
TW340849B (en) Novel cyclopeptides and pharmaceutical compositions as integrin inhibitors comprizing the same
ECSP961741A (es) Insulina de caneda sencilla con alta bioactividad (
WO1999043701A3 (en) Peptides for inhibition of apoptosis and pharmaceutical compositions containing them
ES541194A0 (es) Un procedimiento de preparacion de inhibidores de la renina que contienen estatina o sus derivados.